FDA Approves the First Oral GLP-1 Drug for Obesity copertina

FDA Approves the First Oral GLP-1 Drug for Obesity

FDA Approves the First Oral GLP-1 Drug for Obesity

Ascolta gratuitamente

Vedi i dettagli del titolo

3 mesi a soli 0,99 €/mese

Dopo 3 mesi, 9,99 €/mese. Si applicano termini e condizioni.

A proposito di questo titolo

In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the Wegovy Pill for Obesity" and more.

Related Content:

  • What to Know About the Wegovy Pill for Obesity
Ancora nessuna recensione